EID Parry Completes Acquisition of Valensa International
Producer of Astaxanthin, Premium Nutraceutical Ingredients & Formulations Poised for Growth
LAS VEGAS, Oct. 11, 2011 — E.I.D.-Parry (India) Limited, the bioproducts and nutraceutical division of the Murugappa Group, has announced the acquisition of 100% of the voting shares of U. S. Nut…
Valensa Launches Omega Joe(TM) ALA as a Daily Source of Plant-Based ALA Omega-3
Super Critical DeepExtract(R) of Perilla Responds to Research Showing ALA Supplementation Offers Solid Support for Cardiovascular Health and Overall Well-Being
LAS VEGAS, Oct. 22, 2010 — Valensa International (Eustis, FL USA) announced today that it has launched a new high-quality, superc…
Valensa and Mercola Health Resources Announce Innovative Joint Health Product
New Flex Pro ES(TM) – a proprietary one-a-day four-component joint health formulation – will be offered on the mercola.com website
ORLANDO, Fla., Oct. 20, 2010 — Valensa International (Eustis, FL USA) and Mercola Health Resources, LLC (Hoffman Estates, IL) announced today that t…
Valensa Teams with Aker BioMarine on Superba(TM) Krill Oil-Based Formulations for Joint Health and Eye Health Dietary Supplements
Exclusive Worldwide Agreement Will Allow Valensa to Develop Next-Generation Omega-3 Condition-Specific Formulations
ORLANDO, Fla., Dec. 8, 2009 — Valensa International (Eustis, FL USA) announced today that it has reached an exclusive agreement with Aker BioMarine ASA (Oslo, Norway) to us…